Cutaneous fibrous dysplasia: An incomplete form of the mccune-albright syndrome

Dermatology

Volumn 192, Issue 3, 1996, Pages 258-261

  Schwartz, R A ^a   Spicer, M S ^a   Leery, C B ^a   Ticker, J B ^a   Lambert, W C ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Cutaneous fibrous dysplasia; McCune Albright syndrome; Scalp alopecia

Indexed keywords

ADULT; ALBRIGHT SYNDROME; ALOPECIA; ARTICLE; CAFE AU LAIT SPOT; CASE REPORT; DIFFERENTIAL DIAGNOSIS; FEMALE; FIBROUS DYSPLASIA; HAIR FOLLICLE; HISTOLOGY; HUMAN; PRECOCIOUS PUBERTY; PRIORITY JOURNAL; SOMATIC MUTATION;

EID: 0029875027     PISSN: 10188665     EISSN: 14219832     Source Type: Journal    
DOI: 10.1159/000246379     Document Type: Article

References (16)

1. Albright F, Butler AM, Hampton AO, Smith P: Syndrome characterized by osteitis fibrosa disseminata. areas of pigmentation and endocrine dysfunction, with precocious puberty in females: Report of five cases. N Engl J Med 1937:216:727-746.
2. McCune DJ: Osteitis fibrosa cystica: The case of a nine-year-old girl who also exhibits precocious puberty, multiple pigmentation of the skin and hyperthyroidism. Am J Dis Child 1936:52:743-744.
3. McCune DJ. Bruch H: Osteodystrophica fibrosa. Am J Dis Child 1937;54:806-848.
4. Malchoff CD. Reardon G. MacGillivray DC, et al: An unusual presentation of McCunc-Albright syndrome confirmed by an activating mutation of the G, a-subunit from a bone lesion. J Clin Endocrinol Metab 1994:78: 803-806.
5. Shenker A, Weinstein LS, Sweet DE, et al: An activating G, a mutation is present in fibrous dysplasia of bone in the McCune-Albright syndrome. J Clin Endocrinol Metab 1994:79:750-755.
6. Shelley WB, Wood MG: Alopecia with fibrous dysplasia and osteomas of skin: A sign of polyostotic fibrous dysplasia. Arch Dermatol 1976:112:715-719.
7. Weinstein LS, Shenker A. Gejman PV. et al: Activating mutations of the stimulatory C protein in the McCunc-Albright syndrome. N Engl J Med 1991:325:1688-1695.
8. Levine MA: The McCune-Albright syndrome: The whys and wherefores of abnormal signal transduction. N Engl J Med 1991;325: 1738-1740.
9. Shenker A, Weinstein LS. Moran A, et al: Severe endocrine and nonendocrine manifestations of the McCune-Albright syndrome associated with activating mutations of stimulatory G protein G,. J Pediatr 1993:123:509-518.
10. Crowe FW, Schull WJ: Diagnostic importance of cafe-au-lait spot in neurofibromatosis. Arch Intern Med 1953:91:758-766.
11. Benedict PH. Szabo G, Fitzpatrick TC. et al: Melanotic macules in Albright’s syndrome and in neurofibromatosis. J Am Med Assoc 1968; 205:618-626.
12. Riccardi VM: Neurofibromatosis and Albright’s syndrome. Dermatol Clin 1987:5: 193-203.
13. Pierini AM. Ortonne J-P, Floret D: Signes dermatologiques du syndrome de McCune-Albright. Ann Dermatol Vencreol 1981:108: 969-976.
14. Eyre WG, Reed WB: Albright's hereditary osteodystrophy with cutaneous bone formation. Arch Dermatol 1971; 104:635-642.
15. Patten JL. Johns DR. Valle D. et al: Mutation in the gene encoding the stimulatory G protein of adenylate cyclase in Albright's hereditary osteodystrophy. N Engl J Med 1990:322: 1412-1419.
16. Mirie A, Vechio JD, Levine MA: Heterogenous mutations in the gene encoding the alpha-subunit of the stimulatory G protein of adenylyl cyclase in Albright hereditary osteodystrophy. J Clin Endocrinol Metab 1993; 76:1560-1568.